Madison hospitals try to coordinate care, avoid Medicare penalties
He was born with a rare chromosome deletion that makes it difficult for him to swallow and breathe. He uses a feeding tube, wears a breathing machine at night and sometimes requires oxygen during the day. He has low muscle tone, vision impairment, high ...
Madison.com - Sun, 19 Oct 2014 11:11

Whole-genome sequencing reveals new types of autism risk
For example, one individual inherited a deletion in CACNA2D from his father, a deletion in ARID1B from his mother and another deletion from his mother just 5 kilobases away from SCN2A, a strong autism candidate. Traditional sequencing methods would not ...
SFARI News - Mon, 20 Oct 2014 10:03

Personalis, Garvan Institute to Provide Genome Sequencing, Analysis to ...
Jeramiah Smith, assistant professor of biology at the University of Kentucky, discusses the use of PicoPLEX DNA-seq for de novo sequencing of single amphibian chromosomes, while John Langmore, co-founder and chief scientific officer of Rubicon, details ...
GenomeWeb - Mon, 20 Oct 2014 10:03



This Week in PLOS
Jeramiah Smith, assistant professor of biology at the University of Kentucky, discusses the use of PicoPLEX DNA-seq for de novo sequencing of single amphibian chromosomes, while John Langmore, co-founder and chief scientific officer of Rubicon, details ...
GenomeWeb (blog) - Mon, 20 Oct 2014 09:18

Pharmacyclics Files Supplemental New Drug Application for IMBRUVICA® for ...
... lymphoma (MCL) or chronic lymphocytic leukemia (CLL) who have received at least one prior therapy, and for CLL patients with a deletion of the short arm of chromosome 17 (del 17p), including treatment-naive and previously treated del 17p CLL patients.
PR Newswire (press release) - Mon, 20 Oct 2014 05:00

Pharmacyclics files Imbruvica sNDA for Waldenstrom's macroglobulinemia
... lymphoma (MCL) or chronic lymphocytic leukemia (CLL) who have received at least one prior therapy, and for CLL patients with a deletion of the short arm of chromosome 17 (del 17p), including treatment-naive and previously-treated del 17p CLL patients.
The Pharma Letter - Mon, 20 Oct 2014 08:33

Van Andel, Sidney Kimmel Receive $7.5M for Epigenetics Studies into Cancer
Jeramiah Smith, assistant professor of biology at the University of Kentucky, discusses the use of PicoPLEX DNA-seq for de novo sequencing of single amphibian chromosomes, while John Langmore, co-founder and chief scientific officer of Rubicon, details ...
GenomeWeb - Mon, 20 Oct 2014 10:26

Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy
Furthermore, the drug is also used to treat CLL in both treatment-na├»ve and treatment-experienced patients with deletion of the short arm of chromosome 17. Gazyva, on the other hand, is marketed by Roche in combination with chlorambucil (a chemotherapy ...
Zacks.com - Fri, 17 Oct 2014 14:11

Pharmacyclics' (PCYC) IMBRUVICA Approved in Europe for Treatment of Two ...
StreetInsider.com (subscription) - Fri, 17 Oct 2014 05:45

Pharmacyclics and Roche research Imbruvica and Gazyva
The Pharma Letter - Fri, 17 Oct 2014 04:37


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014